![Ferulic-acid-Coniferic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁](http://file4.renrendoc.com/view/29f31681b44076d6b7f2425ded17c820/29f31681b44076d6b7f2425ded17c8201.gif)
![Ferulic-acid-Coniferic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁](http://file4.renrendoc.com/view/29f31681b44076d6b7f2425ded17c820/29f31681b44076d6b7f2425ded17c8202.gif)
![Ferulic-acid-Coniferic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁](http://file4.renrendoc.com/view/29f31681b44076d6b7f2425ded17c820/29f31681b44076d6b7f2425ded17c8203.gif)
![Ferulic-acid-Coniferic-acid-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁](http://file4.renrendoc.com/view/29f31681b44076d6b7f2425ded17c820/29f31681b44076d6b7f2425ded17c8204.gif)
下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEFerulic acidCat. No.: HY-N0060CAS No.: 1135-24-6Synonyms: Coniferic acid分式: CHO分量: 194.18作靶點(diǎn): FGFR作通路: Protein Tyrosine Kinase/RTK儲(chǔ)存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 100 mg/mL (
2、514.99 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 5.1499 mL 25.7493 mL 51.4986 mL5 mM 1.0300 mL 5.1499 mL 10.2997 mL10 mM 0.5150 mL 2.5749 mL 5.1499 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請注意儲(chǔ)備液的保存式和期限。體內(nèi)實(shí)驗(yàn)請根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥式選擇適當(dāng)?shù)娜芙獍福渲魄罢埾扰渲瞥吻宓膬?chǔ)備液,再依次添加助溶劑(為保證實(shí)驗(yàn)結(jié)果的可靠性,體內(nèi)實(shí)驗(yàn)的作液,建議您現(xiàn)現(xiàn)配,當(dāng)
3、天使;澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;以下溶劑前的百分 指該溶劑在您配制終溶液中的體積占):1. 請依序添加每種溶劑: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (12.87 mM); Clear solution2. 請依序添加每種溶劑: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (12.87 mM); Clear solution3. 請依序添加每種溶劑: 10% DMSO 90% corn oil1/3 Master of
4、Small Molecules 您邊的抑制劑師www.MedChemESolubility: 2.5 mg/mL (12.87 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Ferulic acid種新型的成纖維細(xì)胞長因受體 1 (FGFR1) 抑制劑, 對(duì)于 FGFR1 和 FGFR2 的 IC50值分別為3.78 and 12.5 M。IC50 & Target IC50: 3.78 M (FGFR1), 12.5 M (FGFR2) 1體外研究 Ferulic acid (FA) is a novel fibroblast growth factor
5、 receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 M for FGFR1 and FGFR2, respectively. Ferulic acid exhibits great inhibitory activity on FGFR1 with aninhibitory rate of 92% at 1 M. The proliferation of HUVEC stimulated by FGF1 is markedly decreased afterFerulic acid treatment ranging from 5
6、 to 40 M for 24 h. Ferulic acid does not exert significant cell viability upto 20 M, but over 30 M Ferulic acid exhibits a cytotoxic effect in HUVEC compare to the control. Ferulicacid inhibits FGF1-induced HUVEC migration and invasion in a dose-dependent manner. Ferulic acidmarkedly suppresses the
7、FGF1-induced phosphorylation of PI3K and Akt. Ferulic acid treatmentssignificantly inhibit MMP-2 and MMP-9 expression stimulated by FGF1 1.體內(nèi)研究 Treatment with Ferulic acid (FA) potently inhibits FGF1-induced neovascularization. It is found thatintragastric administration of Ferulic acid markedly inh
8、ibits tumor volume and tumor weight, as compare tothe counterparts treated with DMSO. Furthermore, Ferulic acid treatment is well tolerated, and there is nosignificant difference in weight between the vehicle group and the FA-treated groups 1. Ferulic acid (0.01,0.1, 1 or 10 mg/kg) given by oral rou
9、te decreases significantly the immobility time in the forced swimming test(FST) and tail suspension test (TST), whereas produces no effect in the open-field test. Results demonstratethat the administration of Ferulic acid (0.001 mg/kg, p.o.) boosts the antidepressant-like effect of fluoxetine (5mg/k
10、g, p.o.) in the TST 2.PROTOCOLCell Assay 1 HUVEC (5104 cells/well) are plated onto a gelatinized 24-well culture plate and cultured in ECGS containing15% FBS. HUVEC are treated with DMSO (0.1%) or different concentrations of Ferulic acid (FA) (0, 2.5, 5,10, 20, 30, 40 M) for 24 h. Cell viability is
11、determined by the MTT assay. After 4 h of incubation, theabsorbance is measured at 450 nm with a microplate reader. The results are calculated from six replicates ofeach experiment. Three independent experiments are performed 1.MCE has not independently confirmed the accuracy of these methods. They
12、are for reference only.Animal Male Swiss mice (30 to 40 g) are maintained at 21 to 23C with free access to water and food, under a 12:12Administration 2 h light/dark cycle (lights on at 07:00 h). All manipulations are carried out between, 9:00 and 16:00 h, witheach animal used only once. In order to
13、 investigate the antidepressant-like effect of Ferulic acid, Ferulic acidis administered at a dose range of 0.001 to 10 mg/kg, by oral route (p.o.) 60 min before the forced swimmingtest (FST), tail suspension test (TST) or open-field test. The control animals receive appropriate vehicle 2.MCE has no
14、t independently confirmed the accuracy of these methods. They are for reference only.2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEREFERENCES1. Yang GW, et al. Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-MediatedAngiogenesis. Int J Mol Sci. 2015 Oct 12;16(10):24011-31.2. Zeni AL, et al. Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of theserotonergic system. Eur J Pharmacol. 2012 Ma
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- GB/T 19183.2-2024電氣和電子設(shè)備機(jī)械結(jié)構(gòu)戶外機(jī)殼第2部分:協(xié)調(diào)尺寸
- PB-22-N-4-Hydroxypentyl-3-carboxyindole-metabolite-生命科學(xué)試劑-MCE-7583
- EMPO-生命科學(xué)試劑-MCE-2695
- 二零二五年度自動(dòng)駕駛車輛測試與示范運(yùn)營合同
- 二零二五年度健康產(chǎn)品銷售折扣與會(huì)員管理系統(tǒng)合同
- 2025年度體育設(shè)施建設(shè)與運(yùn)營簽合同授權(quán)委托書
- 2025年度董事薪酬體系設(shè)計(jì)與聘任合同
- 2025年度荒山開發(fā)使用權(quán)出讓合同
- 2025年度林業(yè)保護(hù)駕駛員聘用與巡護(hù)服務(wù)合同
- 二零二五年度船舶船員勞動(dòng)合同及船舶事故應(yīng)急處理合同
- GB/T 19228.1-2024不銹鋼卡壓式管件組件第1部分:卡壓式管件
- 2024年計(jì)算機(jī)二級(jí)WPS考試題庫380題(含答案)
- (高清版)DZT 0399-2022 礦山資源儲(chǔ)量管理規(guī)范
- 初一英語英語閱讀理解專項(xiàng)訓(xùn)練15篇
- 2023年山西國際能源集團(tuán)有限公司招聘筆試題庫及答案解析
- 部編人教版五年級(jí)道德與法治下冊全冊課件(完整版)
- 廣西貴港市2023年中考物理試題(原卷版)
- 仁愛英語八年級(jí)閱讀理解測試題和答案
- DB11∕T 1875-2021 市政工程施工安全操作規(guī)程
- 傳統(tǒng)節(jié)日春節(jié)英文介紹課件
- 水資源論證報(bào)告
評(píng)論
0/150
提交評(píng)論